Alkermes
disciplined capital allocation supports highest roi priorities advance alfa initiate studies to support potential registration pathways in mucosal melanoma and platinum resistant ovarian cancer continued enrollment in artistry dose expansion evaluating subcutaneous anti tumor activity continue to build objective response data in multiple tumor types in artistry and artistry go | Alkermes
Company
Deck Type
Sector
Industry
Deck date
March 2021
Slide
29 of 144
Related slides by other companies
Adobe
Investor Day
October 2022
capital allocation priorities | Adobe
Ulta Beauty
Investor Day
October 2021
capital allocation priorities | Ulta Beauty
Synchrony Financial
Investor Day
September 2021
executing a disciplined capital allocation strategy pets best | Synchrony Financial
Compass Group
Results
May 2022
clear capital allocation priorities | Compass Group
Other recent decks by Alkermes
See all presentations (22 decks)
Investor Conference
January 2024
Results
October 2023
Investor Presentation
October 2023
Results
July 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights